Format

Send to

Choose Destination
Development. 2014 Jan;141(1):219-23. doi: 10.1242/dev.103341.

Cas9 effector-mediated regulation of transcription and differentiation in human pluripotent stem cells.

Author information

1
Diabetes Center of Excellence, University of Massachusetts Medical School, Worcester, MA 01605, USA.

Abstract

The identification of the trans-acting factors and cis-regulatory modules that are involved in human pluripotent stem cell (hPSC) maintenance and differentiation is necessary to dissect the operating regulatory networks in these processes and thereby identify nodes where signal input will direct desired cell fate decisions in vitro or in vivo. To deconvolute these networks, we established a method to influence the differentiation state of hPSCs with a CRISPR-associated catalytically inactive dCas9 fused to an effector domain. In human embryonic stem cells, we find that the dCas9 effectors can exert positive or negative regulation on the expression of developmentally relevant genes, which can influence cell differentiation status when impinging on a key node in the regulatory network that governs the cell state. This system provides a platform for the interrogation of the underlying regulators governing specific differentiation decisions, which can then be employed to direct cellular differentiation down desired pathways.

KEYWORDS:

CRISPR; Cas9; Differentiation; Gene activation; Pluripotent stem cell; Transcriptional repression

PMID:
24346702
PMCID:
PMC3865759
DOI:
10.1242/dev.103341
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center